Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Pazopanib prolongs progression-free survival in patients with advanced soft-tissue Sarcoma

Written by | 31 Jul 2012

by Bruce Sylvester – Emerging uses of FDA Approved Drugs – Treatment with pazopanib nearly tripled progression-free survival (PFS), compared with placebo, among patients with metastatic soft-tissue sarcoma… read more.

Hormone-depleting drug appears to have efficacy in localized high-risk prostate tumors

Written by | 31 Jul 2012

by Bruce Sylvester – Emerging uses of FDA Approved Drugs – A hormone-depleting drug approved in 2011 for the treatment of metastatic prostate cancer appears to help eliminate… read more.

Benefit of statins confirmed for persons without history of vascular disease

Written by | 31 Jul 2012

A meta-analysis confirms that statin therapy lowers the risk of major vascular events by about a fifth among subjects with no history of vascular disease, male and female,… read more.

ILTS 2012 Report – Stereotactic body radiation therapy may help HCC patients on liver transplant list

Written by | 28 Jun 2012

by Thomas R. Collins – Stereotactic body radiation therapy (SBRT), or radiosurgery, is effective in treating hepatocellular cancer (HCC) tumours that are unresectable and it can act as… read more.

ILTS 2012 Report – Regulatory T-cell injection holds promise for inducing tolerance

Written by | 28 Jun 2012

by Thomas R. Collins – Injection of regulatory T cells could prove to be a powerful method of inducing tolerance among liver transplantation patients,

Little benefit in imaging tests for women with breast pain

Written by | 14 Jun 2012

by Bruce Sylvester – Women with breast pain who undergo extra-routine mammograms, MRIs or ultrasounds as part of breast pain evaluation derive no diagnostic or therapeutic benefit, researchers… read more.

Duloxetine appears to relieve chemotherapy-related neuropathic pain

Written by | 14 Jun 2012

Paper presented on 5th June at ASCO – by Bruce Sylvester – The antidepressant duloxetine (Cymbalta ®), relieves  neuropathic pain caused by chemotherapy in 59 percent of patients,… read more.

Changes in smoking significantly impacts lung cancer mortality in the U.S. : 1975-2000

Written by | 14 Jun 2012

by Bruce Sylvester – Researchers report that, in the last quarter of the 20th century, changes in smoking behaviors have led to a significant drop in lung cancer… read more.

Ipilimumab looks promising in shrinking/slowing melanoma brain metastases

Written by | 14 Jun 2012

Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Researchers from a phase 2 study published  on March 27 in The Lancet Oncology  report that ipilimumab,… read more.

Largest study to date confirms efficacy of botulinum toxin treatment for overactive bladder

Written by | 14 Jun 2012

Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Results from the largest study yet of the treatment of urinary incontinence with botulinum toxin suggests that… read more.

Evidence growing that aspirin helps prevent cancer

Written by | 14 Jun 2012

Taken from The Lancet – by Bruce Sylvester – Two papers published in March, 2012 in The Lancet suggest that daily aspirin use can be protective against cancer.

US health care: doing less with more

Written by | 14 Jun 2012

World Health Matters (U.S.A.) – by Gary Finnegan – The United States is paying far more for health services than 12 comparable industrialised nations but the quality of… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.